)
NOSIUM (NOSIUM ) investor relations material
NOSIUM Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 2026 marked a transformative period with focus on the reverse acquisition of Medicortex Finland Oyj and portfolio streamlining, including the sale of Dr Sannas Sweden AB to strengthen liquidity and align with new strategic direction.
Secured a SEK 4 million interest-free bridge loan to meet NGM's capital requirements for the planned acquisition.
Medicortex's collaboration with the US DoD on TBI diagnostics was extended, validating the target's technology.
Financial highlights
Group net sales decreased by 19% to SEK 1,094k (1,345k) year-over-year; parent company sales rose 1% to SEK 80k (79k).
Group operating loss widened to SEK -902k (-864k); parent company operating loss at SEK -672k (-546k).
Group net result attributable to shareholders improved to SEK -901k (-1,130k); parent company net result at SEK -666k (-712k).
Group cash flow from operations improved to SEK -143k (-839k); parent company to SEK 33k (-518k).
Group equity ratio increased to 80% (75%); parent company at 82% (86%).
Outlook and guidance
The company is progressing toward transformation into a medtech-focused entity, pending NGM approval of the Medicortex acquisition.
Portfolio streamlining and capital strengthening are expected to support the new strategic direction.
- 2025 saw declining revenue and losses amid a strategic shift to medtech via the Medicortex merger.NOSIUM
Q4 202520 Feb 2026 - Positive Q3 results and a transformative medtech acquisition mark a pivotal quarter.NOSIUM
Q3 202527 Nov 2025 - Cost reductions and divestments improved results amid ongoing strategic transformation.NOSIUM
Q2 202528 Aug 2025 - Sharp revenue decline and major restructuring, including a reverse acquisition and share issue.NOSIUM
Q3 202413 Jun 2025 - Sharp revenue drop offset by improved equity and new capital; cost cuts and divestments ongoing.NOSIUM
Q2 202413 Jun 2025 - Operating losses narrowed and cost base improved as NOSIUM targets new structural deals.NOSIUM
Q1 20256 Jun 2025 - Sharp revenue drop and asset write-downs, but improved equity and cost control.NOSIUM
Q4 20246 Jun 2025
Next NOSIUM earnings date
Next NOSIUM earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage